Transdermal patches: a recent approach to new drug delivery system S Dhiman, TG Singh, AK Rehni Int J Pharm Pharm Sci 3 (5), 26-34, 2011 | 202 | 2011 |
Role of nuclear factor kappa B (NF-κB) signalling in neurodegenerative diseases: an mechanistic approach S Singh, TG Singh Current Neuropharmacology 18 (10), 918-935, 2020 | 155 | 2020 |
Mechanistic insights and perspectives involved in neuroprotective action of quercetin AK Grewal, TG Singh, D Sharma, V Sharma, M Singh, MH Rahman, ... Biomedicine & Pharmacotherapy 140, 111729, 2021 | 152 | 2021 |
Traumatic brain injury: mechanistic insight on pathophysiology and potential therapeutic targets K Thapa, H Khan, TG Singh, A Kaur Journal of Molecular Neuroscience 71 (9), 1725-1742, 2021 | 148 | 2021 |
Neuropathology of drug addictions and substance misuse volume 1: foundations of understanding, tobacco, alcohol, cannabinoids and opioids VR Preedy Academic Press, 2016 | 103 | 2016 |
Apoptotic pathways and Alzheimer’s disease: probing therapeutic potential VK Sharma, TG Singh, S Singh, N Garg, S Dhiman Neurochemical research 46 (12), 3103-3122, 2021 | 92 | 2021 |
Pharmacological preconditioning of the brain: a possible interplay between opioid and calcitonin gene related peptide transduction systems. AK Rehni, TG Singh, AS Jaggi, N Singh Pharmacological Reports 60 (6), 904, 2008 | 87 | 2008 |
CRC concise encyclopedia of nanotechnology BI Kharisov, OV Kharissova, U Ortiz-Mendez CRC Press, 2016 | 84 | 2016 |
Medicinal plants used against various inflammatory biomarkers for the management of rheumatoid arthritis S Singh, TG Singh, K Mahajan, S Dhiman Journal of Pharmacy and Pharmacology 72 (10), 1306-1327, 2020 | 82 | 2020 |
Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine (H1) receptor activation-linked mechanism AK Rehni, TG Singh, N Singh, S Arora Naunyn-Schmiedeberg's archives of pharmacology 381, 11-19, 2010 | 80 | 2010 |
Chronic Stress And Diabetes Mellitus: Interwoven Pathologies. S Vivek, Kumar, S Thakur, Gurjeet Curr Diabetes Rev., 2019 | 79* | 2019 |
Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease V Sharma, A Kaur, TG Singh Biomedicine & Pharmacotherapy 129, 110373, 2020 | 75 | 2020 |
Alzheimer's Disorder: Epigenetic connection and associated risk factors. VK Sharma, V Mehta, TG Singh Curr Neuropharmacol, 2020 | 73 | 2020 |
Dysbiosis and Alzheimer’s disease: a role for chronic stress? VK Sharma, TG Singh, N Garg, S Dhiman, S Gupta, MH Rahman, A Najda, ... Biomolecules 11 (05), 678, 2021 | 60 | 2021 |
Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases K Thapa, H Khan, U Sharma, AK Grewal, TG Singh Life Sciences 267, 118975, 2021 | 59 | 2021 |
Nanobiomaterials in cosmetics: current status and future prospects TG Singh, N Sharma Nanobiomaterials in galenic formulations and cosmetics, 149-174, 2016 | 59 | 2016 |
CREB: a multifaceted target for Alzheimer’s disease VK Sharma, TG Singh Current Alzheimer Research 17 (14), 1280-1293, 2020 | 58 | 2020 |
Gastroretentive: a controlled release drug delivery system S Dhiman, TG Singh, AK Rehni, S Sood, S Arora Asian J Pharm Clin Res 4 (SUPPL 1), 5-13, 2011 | 50 | 2011 |
Pharmacological modulation of ubiquitin-proteasome pathways in oncogenic signaling A Sharma, H Khan, TG Singh, AK Grewal, A Najda, ... International Journal of Molecular Sciences 22 (21), 11971, 2021 | 45 | 2021 |
Sirtuin acetylation and deacetylation: a complex paradigm in neurodegenerative disease H Khan, P Tiwari, A Kaur, TG Singh Molecular Neurobiology 58, 3903-3917, 2021 | 45 | 2021 |